Fig. 3.
(A) Overall survival for BCL6-rearrangement positive (n = 36) and BCL6-rearrangement negative (n = 80) lymphomas. (B) DFS for BCL6-rearrangement positive (n = 19) and BCL6-rearrangement negative (n = 45) lymphomas.
(A) Overall survival for BCL6-rearrangement positive (n = 36) and BCL6-rearrangement negative (n = 80) lymphomas. (B) DFS for BCL6-rearrangement positive (n = 19) and BCL6-rearrangement negative (n = 45) lymphomas.
